本页面由Tiger Trade Technology Pte. Ltd.提供服务

Neurosense Therapeutics Ltd

3.48
-0.1800-4.92%
成交量:7,424
成交额:2.61万
市值:657.13万
市盈率:-0.40
高:3.66
开:3.66
低:3.28
收:3.66
52周最高:26.64
52周最低:3.28
股本:188.83万
流通股本:129.23万
量比:0.50
换手率:0.57%
股息:- -
股息率:- -
每股收益(TTM):-8.7319
每股收益(LYR):-8.7319
净资产收益率:-2174.98%
总资产收益率:-247.30%
市净率:-4.21
市盈率(LYR):-0.40

数据加载中...

2023/08/14

SEC问询函

Form CORRESP - Correspondence
2023/07/21

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2023/04/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/22

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/26

SEC问询函

CORRESP [Cover] - Correspondence
2022/04/14

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/12/30

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/06

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/06

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/06

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/12/06

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/11/19

SEC问询函

CORRESP [Cover] - Correspondence
2021/11/19

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/11/10

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers